Clinical Trial Update: Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial investigating anetumab ravtansine combined with atezolizumab in mesothelin-positive advanced non-small cell lung cancer; study terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anetumab Ravtansine (anetumab ravtansine)
• Atezolizumab (atezolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Mesothelin Positive, Stage III Non-Small Cell Lung Cancer AJCC v7 | Phase 1 | Status: TERMINATED | Results posted: 2020-05-15